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Abstract Considering tobacco smoke as one of the most
health-relevant indoor sources, the aim of this work was to
further understand its negative impacts on human health. The
specific objectives of this work were to evaluate the levels of
particulate-bound PAHs in smoking and non-smoking homes
and to assess the risks associated with inhalation exposure to
these compounds. The developed work concerned the appli-
cation of the toxicity equivalency factors approach (including
the estimation of the lifetime lung cancer risks, WHO) and the
methodology established by USEPA (considering three dif-
ferent age categories) to 18 PAHs detected in inhalable (PM10)
and fine (PM2.5) particles at two homes. The total concentra-
tions of 18 PAHs (ΣPAHs) was 17.1 and 16.6 ng m
−3 in PM10
and PM2.5 at smoking home and 7.60 and 7.16 ng m
−3 in
PM10 and PM2.5 at non-smoking one. Compounds with five
and six rings composed the majority of the particulate PAHs
content (i.e., 73 and 78 % of ΣPAHs at the smoking and non-
smoking home, respectively). Target carcinogenic risks
exceeded USEPA health-based guideline at smoking home
for 2 different age categories. Estimated values of lifetime
lung cancer risks largely exceeded (68–200 times) the
health-based guideline levels at both homes thus
demonstrating that long-term exposure to PAHs at the respec-
tive levels would eventually cause risk of developing cancer. 
The high determined values of cancer risks in the absence of 
smoking were probably caused by contribution of PAHs from 
outdoor sources.
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Introduction
It is well known that tobacco smoking is associated with 
various diseases of lung and heart as well as with cancers of 
various organ systems (IARC 2004, 2010). Tobacco smoke is 
certainly one of the greatest sources of the indoor pollution not 
only for the smokers but also for all those who are somehow 
exposed to it. The scientific research has shown that exposure 
to second-hand smoke, also referred as environmental tobacco 
smoke (ETS), is associated with various adverse health out-
comes including increased risk of lung cancer, acute coronary 
syndromes and stroke, an increased prevalence of respiratory 
symptoms and inflammatory reactions (Adlkofer 2001; 
Barnoya and Glantz 2005; Bhalla et al. 2009; Cesaroni et al. 
2008; Dransfield et al. 2007; Hoffmann and Hoffmann 1997; 
Madureira et al. 2012; Raupach et al. 2008). Thus, the US 
Environmental Protection Agency (USEPA) and International 
Agency for Research on Cancer (IARC) have classified ex-
posure to tobacco smoke as Class A and 1 human carcinogen, 
respectively (IARC 2004; USEPA 1993). Considering the 
negative health impacts, USA and a number of European 
countries have ban smoking in public places (McNabola and 
Gill 2009) in order to ensure smoke-free environments and to 
protect public health (Madureira et al. 2012; Pacheco et al. 
2012; WHO  2009). However, for individuals that spent large 
amounts of their time at homes (seniors, infants) the exposures
to tobacco smoke in the respective ambiences are relevant.
Young children in particular are in great risks; it was estimated
that four out of ten children (approximately 700 million chil-
dren globally) have at least one parent who currently smokes
(IARC 2012), thus predisposing them to exposure to second-
hand tobacco smoke at their homes. In Europe, the prevalence
of children exposure to tobacco smoke at homes is particularly
high (78 %) being the highest of all geographical regions
(WHO 2009). In order to protect the public health, it is thus
necessary to continue with scientific and regulatory efforts to
reduce tobacco-related pollution.
From the chemical point of view, tobacco smoke is a
complex mixture of gaseous components and particles of
different sizes. Up to 5,200 components, including heavy
metals, aromatic amines and N-nitrosamines have been iden-
tified in tobacco smoke (Rodgman and Perfetti 2008), as well
as 549 polycyclic aromatic hydrocarbons (PAHs; Thielen
et al. 2008). PAHs are a large group of organic compounds
with two or more fused aromatic rings that are produced
during incomplete combustion of organic matter. Indoors
tobacco smoke is considered among their most significant
source (Ball and Truskewycz 2013). PAHs are cytotoxic and
mutagenic compounds, some of them being considered as
carcinogens to humans (WHO 1998). In air, PAHs are distrib-
uted between gas phase and particles, but the especially harm-
ful compounds (with five to six aromatic rings) are predom-
inantly found in particulates, mostly due to their high molec-
ular weights and low volatility (Liu et al. 2001; Lu and Chen
2008; Slezakova et al. 2011). Because of their hazardous
properties there have been efforts to regulate PAHs in air.
Current European legislation on ambient air (Directive
2004/107/EC 2005) sets annual target value of 1 ng m−3 for
carcinogenic PAHs in PM10 (particulate matter with aerody-
namic diameter below 10 μm) using benzo[a ]pyrene as indi-
cator of carcinogenic PAHs. Benzo[a ]pyrene is probably the
most studied carcinogenic compound and is often used as a
surrogate for other carcinogenic PAHs in studies estimating
human cancer risks. However, the suitability of this approach
started to be questioned (Pufulete et al. 2004) by new findings
on the presence of more potent PAHs, such as
dibenzo[a ,l ]pyrene or dibenz[a ,h ]anthracene (Okona-
Mensah et al. 2005).
Considering tobacco smoke among the most health-
relevant indoor emission sources, this work aims to evaluate
the associated health risks regarding particulate-bound PAHs.
The developed work concerns the application of the toxicity
equivalency factors (Boström et al. 2002) approach (including
the estimation of the lifetime lung cancer risks; WHO 1987,
2000) and the methodology established by USEPA (2013) to
18 PAHs detected in inhalable (PM10) and fine (PM2.5) parti-
cles at one home influenced by smoking and one non-smoking
home. The determined compounds were the 16 PAHs consid-
ered by USEPA as priority pollutants, dibenzo[a ,l ]pyrene,
and benzo[j ]fluoranthene (the latter recommended by EU
Directive 2004/107/EC 2005).
Materials and methods
Sample collection
Particulate-bound PAHs were collected for a period of 19
consecutive days in January 2009 at two homes situated in
Oporto, Portugal: one influenced by smoking and one non-
smoking home accordingly with Castro et al. (2011). Both
homes were located in the Paranhos district. To avoid dissim-
ilar influence of outdoor air both homes were located in the
same block of flats and on the same floor (fourth). The
characteristics of both homes were similar (i.e., area, cleaning
and cooking activities, number of inhabitants) and are shown
in Table 1S of the Supplementary materials. During the whole
period, the occupants of both homes kept detailed reports of
the performed activities including frequency of ventilation
that was provided by opened windows (as occupants thought
necessary).
The samples were collected daily for a period of 24 h by
constant flow samplers (Bravo H2, TCRTECORA, Italy) that
were combined with PM EN LVS sampling heads (in compli-
ance with norm EN12341 for PM10 and EN14907 for PM2.5).
The air flow rate was 2.3 m3 h−1 which corresponded to less
than 5 % of the room volume sampled per 1 h (in agreement
with available guidelines on indoor air sampling; ISO 16000-
1:2004 2004). Inlets were placed 1.5 m above the floor (in
order to simulate human breathing zone) and minimally 1 m
from the walls, without obstructing the normal usage of the
rooms. Different fractions of particles, i.e., PM10 and PM2.5,
were collected on polytetrafluoroethylene (PTFE) membrane
filters with polymethylpentene support ring (2 μm porosity,
Ø47 mm, SKC Ltd., UK).
During the sampling period, the levels of outdoor air pol-
lutants (PM10, NO2, NOX, O3, SO2 and CO) were registered
(Table 2S of the Supplementary material) as well as meteoro-
logical conditions (Table 3S); the respective station was situ-
ated approximately 350 m east from the homes.
Gravimetric mass determination
PM10 and PM2.5 masses were determined gravimetrically as
described previously in detail by Slezakova et al. (2010,
2013). The PM2.5–10 fraction (i.e., coarse fraction with parti-
cles of aerodynamic diameter between 2.5 and 10 μm) was
determined as difference (by subtraction) between PM10 and
PM2.5.
For the gravimetric mass determination, the filters (76
samples) were stored in Petri dishes and the same analytical
balance (Mettler Toledo AG245 analytical balance weighing
with accuracy of 10 μg) was always used. The steps of
gravimetric mass determinations were the following: 24 h to
equilibrate filters (temperature 22.5±1.0 °C, relative humidity
42±6 %) in a desiccator before weighing, followed by
weighing during the following 24–48 h. After sampling, filters
were immediately weighed, stored in Petri dishes covered in
parafilm, and kept in freezer (−18 °C) until they were further
analyzed.
Extraction and quantification of PAHs
Dibenzo[a ,l]pyrene (D[a ,l]P), benzo[j ]fluoranthene (B[j ]F)
and more 16 PAHs identified as priority pollutants by USEPA
were determined in the collected particulate samples: naphtha-
lene (Nap), acenaphthylene (Acy), acenaphthene (Acp),
fluorene (Flr), phenanthrene (Phe), anthracene (Ant), fluoran-
thene (Flt), pyrene (Pyr), benz[a]anthracene (B[a]A), chrysene
(Chr), benzo[b ]fluoranthene (B[b ]F), benzo[k ]fluoranthene
(B[k ]F), benzo[a ]pyrene (B[a ]P), dibenz[a ,h ]anthracene
(D[a ,h ]A), benzo[ghi ]perylene (B[ghi ]P), indeno[1,2,3-
cd]pyrene (InP); B[j]F and B[b]F (determined as sum B[j+
b]F). The extraction of PAHs from particles (i.e., from PM10
and PM2.5) was performed by MAE (MARS-X 1500 W
Microwave Accelerated Reaction System for Extraction and
Digestion, CEM, Mathews, NC, USA) for 20 min at 110 °C
using 30 mL of acetonitrile (Sigma-Aldrich) (Castro et al.
2009a, b; Ramalhosa et al. 2012). Extracts were carefully
filtered through a PTFEmembrane filter (0.45μm) and reduced
to a small volume using a rotary evaporator (Buchi Rotavapor,
R-200) at 20 °C. A gentle stream of nitrogenwas used to dry the
extracts under low temperature; the residue was then
redissolved in 1,000 μL of acetonitrile immediately before
analysis.
Extracts were analyzed using a Shimadzu LC system
(Shimadzu Corporation, Kyoto, Japan) equipped with a LC-
20AD pump, DGU-20AS degasser and photodiode array
SPD-M20A (PAD) and fluorescence RF-10AXL (FLD) de-
tectors on line. Separation of the compounds was performed in
a C18 column (CC 150/4 Nucleosil 100-5 C18 PAH, 150×
4.0 mm; 5 μm particle size; Macherey-Nagel, Duren,
Germany); the injected volume was 15.0 μL. A mixture of
water (ultra-pure grade; prepared by a Milli-Q simplicity 185
system, Millipore, Molsheim, France) and acetonitrile
(Lichrosol for gradient elution, Carlo Erba, Rodano, Italy,
purity>99.9 %) was used as the mobile phase. The initial
composition of the mobile phase was 50 % of acetonitrile
and 50 % ultra-pure water, and a linear gradient to 100 % of
acetonitrile was programmed in 15 min, with a final hold of
13 min. Initial conditions were reached in 1 min and main-
tained for 6 min before next run. The total run timewas 40min
with a flow rate of 0.8 mL min−1. Fluorescence wavelength
programming was used to perform better sensitivity and min-
imal interference. Each compound was detected at its
optimum excitation/emission wavelength pair: 260/315 nm
(naphthalene, acenaphthene, and fluorene), 260/366 nm
(phenanthrene), 260/430 nm (anthracene, fluoranthene,
pyrene, benz[a ]anthracene, chrysene, benzo[b +j ]
fluoranthene, benzo[k ]fluoranthene, benzo[a ]pyrene,
dibenz[a ,h ]anthracene, benzo[ghi ]perylene and
dibenzo[a ,l ]pyrene), and 290/505 nm (indeno[1,2,3-
cd]pyrene). Acenaphthylene, which does not show fluores-
cence, was analyzed at 254 nm in PAD. Each analysis was
performed at least in triplicate.
Calibration curves obtained using six mixed matrix
matched standards containing all the PAHs showed good
linearity over the entire range of concentrations with correla-
tion coefficients always higher than 0.999 for all PAHs. Limits
of detection (LODs) and limits of quantification (LOQs) were
calculated and expressed as PAH concentration in air samples
(Castro et al. 2009b). LODs between 0.0016 ng m−3 for
benz[a ]anthracene and 0.027 ng m−3 for naphthalene were
obtained, with corresponding LOQs in the range 0.0054–
0.089 ng m−3.
Health risk analysis
The risks associated with inhalation exposure to all 18 PAHs
were assessed by toxicity equivalency factors (TEF) using
values estimated by Muller 1997 (Boström et al. 2002).
Consequently, the lifetime lung cancer risks were estimated
(WHO 1987, 2000).
The carcinogenic risks were assessed according to the meth-
odology provided by USEPA Region III Risk-based
Concentration Table (USEPA 2013). The risks were estimated
as the incremental probability of an individual to develop
cancer, over a lifetime, as a result of inhalation exposure to that
potential carcinogen (i.e., incremental or excess individual life-
time cancer risk; USEPA 1989). Acceptable risk levels for
carcinogens range from 10−4 (risk of developing cancer over
a human lifetime is 1 in 10,000) to 10−6 (risk of developing
cancer over a human lifetime is 1 in 1,000,000). The carcino-
genic risks were calculated using the following equation:
TR ¼ EFr  ED ET IUR Cð Þ=AT½  ð1Þ
where TR is target carcinogenic risk (dimensionless); EFr is the
exposure frequency (350 days year–1); ED is the exposure dura-
tion (years); ET is indoor air exposure time (0.80, i.e., 19.2 h per
day); IUR is the chronic inhalation unit risk (µg m–3)−1 (USEPA
2013); C is the concentration of PAH (µg m–3); and AT is the
number of days over which the exposure is averaged
(25,500 days, i.e. 70 years×365 days year–1). The carcinogenic
risks were estimated only for PAHs for which IUR values are
available (USEPA 2013), namely: naphthalene (IUR of 3.4×
10−5 (μg m−3)−1); chrysene (1.1×10−5 (μg m−3)−1);
benz[a]anthracene, benzo[b]fluoranthene, benzo[k]fluoranthene
and indeno[1,2,3-cd]pyrene (IUR of 1.1×10−4 (μg m−3)−1);
benzo[a ]pyrene (IUR of 1.1×10−3 (μg m−3)−1); and
dibenz[a ,h]anthracene (1.2×10−3 (μg m−3)−1). In this work,
three different age categories (USEPA 2008; Vieira et al. 2011)
were used for the estimation of the target risks using the follow-
ing ED values (in brackets): children 1–3 years (1 year), adults
25–54 years (25 years), and seniors >65 years (65 years). The
lowest possible ED was chosen for each age category in order
not to overestimate the respective cancer risks. The detailed
examples of TR calculations are shown in Table 4S of the
Supplementary material.
Statistical analysis
For the data treatment, the Student’s t test was applied to
determine the statistical significance (p <0.05, two tailed) of
the differences between the determined means.
Results
PM10 and PM2.5 masses
The means and statistical parameters of PM10 and PM2.5
concentrations measured at two homes are summarized in
Fig. 1. The statistical analysis of the results indicated that at
smoking home PM10 and PM2.5 were significantly higher
(p <0.05) than at non-smoking one. In addition, at both homes
PM10 means were not significantly different (p <0.05) from
PM2.5. No significant differences (p <0.05) were observed
between PM levels during weekdays and weekends. PM10
concentrations were well correlated with PM2.5 with correla-
tion coefficients of 0.976 and 0.954 at smoking and non-
smoking home, respectively.
In order to study the relationship between different PM
fractions, mass concentration ratios were also analyzed. The
PM2.5/PM10 ratios were calculated from each measurement.
The mean of PM2.5/PM10 ratios was significantly higher at
smoking home (0.86) where values ranged from 0.81 to 0.97
whereas it was between 0.70 and 0.97 at non-smoking home
(mean of 0.79).
PAHs
The means and concentration range of PAHs in PM10 and
PM2.5 at two homes are summarized in Table 1, with concen-
trations presented as sums of individual compounds (accord-
ing to the number of rings, i.e., groups with 2, 3, 4, 5, and 6
rings, respectively). An increase in PAH molecular weight
globally corresponds to an increase of compound toxicity;
PAHs with five and six rings are among the most harmful
ones. At both homes compounds with five rings that com-
prised of benzo[b+j ]fluoranthene, benzo[k ]fluoranthene,
benzo[a ]pyrene, and dibenz[a ,h ]anthracene were the most
abundant groups of PAHs in both PM10 and PM2.5. These
PAHs accounted for 54 and 59 % of total PAH content (i.e.,
ΣPAHs) at smoking and non-smoking home, respectively. The
highest concentrationswere observed for dibenz[a ,h]anthracene
that reached at the non-smoking home means of 2.25 and
2.11 ng m−3 in PM10 and PM2.5, respectively; at smoking home
its obtained levels were approximately twice higher.
Compounds with six rings were the second most abundant
group of PAHs and accounted for 19 and 20 % of ΣPAHs at
smoking and non-smoking home, respectively. This group com-
prised of benzo[ghi ]perylene, indeno[1,2,3-cd]pyrene, and
dibenzo[a ,l]pyrene that was the least abundant compound of
all PAHs. At non-smoking home, dibenzo[a ,l]pyrene reached
mean concentration of 68.9×10−3 and 61.7×10−3 ng m−3 in
PM10 and PM2.5, respectively, being approximately 3.5 times
lower than at the smoking home. Compounds with four rings
(fluoranthene, pyrene, benz[a ]anthracene, and chrysene)
accounted for 16%ofΣPAHs in both PMat both homes, whereas
it was 11 and 6–7 % of ΣPAHs for compounds with three rings
(fluorene, phenanthrene, anthracene, acenaphthylene, and
acenaphthene) at smoking and non-smoking home, respectively.
Finally, PAHs with two rings that included naphthalene
accounted at smoking home for 1 % of ΣPAHs in both PM; at
non-smoking home these compounds were not found.
Health risks assessment
In order to estimate the carcinogenic risks for humans, the
benzo[a ]pyrene equivalent carcinogenicity were evaluated by
multiplying concentration of each PAH with their TEF value.
The results of TEF-adjusted concentration for 18 PAHs at
smoking and non-smoking home are presented in Table 2.
As expected the higher risks were found for smoking home,
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Fig. 1 PM10 and PM2.5 concentrations at two homes: means, minima and
maxima values, and 25th and 75th percentiles
where total TEF-adjusted concentration of all PAHs (ΣTEF-
PAHs) was 29.0×10
3 pg m−3 in PM10 and 27.4×10
3 pg m−3 in
PM2.5, being approximately 200 % higher than at non-
smoking home. The values of ΣTEF-PAHs at both homes were
then used to estimate the corresponding lifetime lung cancer
risks.
The means and range of target carcinogenic risks associated
with inhalation exposure to PAHs that were estimated by
USEPA methodology are presented in Table 3. The obtained
results demonstrate that: (1) for both PM fractions significantly
higher risks were observed at the smoking home than at the non-
smoking one (Fig. 2); (2) at both homes higher risks (2–11 %)
were found for PM10 than PM2.5; (3) for all compounds, the
highest carcinogenic risks were observed for the age group of
seniors (>65 years); and (4) for all three age-groups the highest
risk were found for dibenz[a ,h]anthracene. Considering the
above-mentioned compounds, the highest cancer risks were
observed for dibenz[a ,h]anthracene which in PM10 at smoking
home reached for seniors a value of 3.86×10−6.
Discussion
The health risks associated with PAHs bound in PM10 and
PM2.5 were evaluated at two homes with and without
smoking. The obtained results showed significantly
(p <0.05) higher levels of both PM10 and PM2.5 at the home
with smoking. Previously, Wallace et al. (2003) estimated an
increase of 37 μg m−3 for indoor particles (range 0.6–5 μm)
due to smoking in a study conducted in USA. BéruBé et al.
(2004) reported PM10 concentration in UK homes with
smokers approximately 10 to 44 μg m−3 greater (depending
upon the number of smokers) than in those without smokers.
Data obtained within this study were similar. Specifically, the
increase between smoking and non-smoking home was
47 μg m−3 for PM10 and 42 μg m
−3 for PM2.5. The average
indoor/outdoor PM10 ratio was 0.65 at the non-smoking
home, which suggests that outdoor air was the major contrib-
utor to indoor PM levels (outdoor PM2.5 data were not avail-
able for comparison). At the smoking home, the average value
of PM10 indoor/outdoor ratio was 2.31 thus indicating the
contribution from indoor sources (i.e., tobacco smoke). It is
however necessary to point that both homes were situated in
Table 1 Mean concentrations of PAHs in PM10 and PM2.5 at smoking and non-smoking homes (ng m
–3)
PAHs Smoking home Non-smoking home
PM10 (n =19) PM2.5 (n=19) PM10 (n=19) PM2.5 (n =19)
Number of rings Mean Range Mean Range Mean Range Mean Range
Two rings 0.126 n.d.–0.402 0.115 n.d.–0.373 n.d. n.d. n.d. n.d.
Three rings 1.81 0.506–4.76 1.77 0.441–4.63 0.467 0.168–0.788 0.478 0.167–0.738
Four rings 2.66 1.57–4.84 2.64 1.53–4.40 1.18 0.355–2.64 1.12 0.365–2.24
Five rings 9.30 2.21–15.6 8.94 2.12–14.5 4.45 1.03–12.0 4.15 1.01–10.5
Six rings 3.21 0.570–5.4 3.13 0.515–5.20 1.50 0.361–3.98 1.41 0.327–3.49
ΣPAHs 17.1 5.07–27.8 16.6 5.05–26.5 7.60 1.91–19.4 7.16 1.87–17.0
n.d. not detected
Table 2 TEF-adjusted mean concentrations of PAHs in PM10 and PM2.5
at two homes (pg m−3)
Smoking home Non-smoking
home
TEFa PM10 PM2.5 PM10 PM2.5
Naphthalene n.a – – – –
Fluorene n.a – – – –
Acenapthylene n.a – – – –
Acenapthene n.a – – – –
Phenanthrene 0.00064 0.365 0.336 0.251 0.253
Anthracene n.a – – – –
Fluoranthene n.a – – – –
Pyrene 0 – – – –
Benz[a]anthracene 0.014 5.26 4.83 4.09 3.84
Chrysene 0.026 22.7 23.9 6.92 6.23
Benzo[b]fluorantheneb 0.11 319 309 146 134
Benzo[k]fluoranthene 0.037 20.3 20.0 9.77 9.10
Benzo[a]pyrene 1 1 400 1 330 610 573
Dibenz[a ,h]anthracene 0.89 3 960 3 800 2 010 1 880
Dibenzo[a ,l]pyrene 100 23 200 21 800 6 890 6 170
Benzo[ghi]perylene 0.012 19.9 19.2 9.84 9.23
Indeno[1,2,3–cd]pyrene 0.067 89.8 88.1 40.7 38.5
∑PAHs – 29 000 27 400 9 720 8 830
n.a. not available
a TEF estimated by Muller, 1997 (Boström et al. 2002)
b Quantified as benzo[b+j]fluoranthene
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the multiunit building. Therefore, infiltration of the second-
hand smoke emissions from other units might potentially
contribute to indoor PM measured at both (smoking and
smoke-free) homes (Dacunto et al. 2013a, King et al. 2013).
Finally, cooking activities were performed at both homes
(Table 1S) and could account for some of the measured PM
(Dacunto et al. 2013b).
The ratios between indoor PM2.5 and PM10 concentrations
that were obtained within this work were in general similar to
those previously reported for indoor environments in Portugal
(0.87 for smoking home and 0.74 non-smoking one;
Slezakova et al. 2009), being considerably higher than those
found outdoors in the same district area (0.68–0.72; Slezakova
et al. 2010, 2011, 2013). High values of PM2.5/PM10 ratios
indicate that indoor PM10 were mostly composed of fine
particles. These findings are health-relevant because fine par-
ticles especially represent a serious risk to human health (Pope
et al. 2002; WHO 2006). In addition, at the smoking home,
PM2.5 concentrations were very high (increase of 280 %) but
PM2.5–10 concentrations were rather low. The significantly
higher PM2.5/PM10 ratio and the much higher PM2.5 concen-
trations at smoking home thus corroborate the previous find-
ings that indoor combustion sources, namely tobacco smoke
had the determinant influence on the presence of fine particles
(Klepeis et al. 2003; Dacunto et al. 2013b).
Considering the protection of public health, it is important
to enhance that at both homes compounds with five and six
rings composed the majority of the particulate PAH content
(i.e., 73 and 78 % of ΣPAHs at the smoking and non-
smoking home, respectively). With the exception of
benzo[ghi ]perylene, all studied five- and six-rings PAHs are
probable and possible human carcinogens (IARC 2010) and
include also benzo[a ]pyrene, a class 1 human carcinogen. The
total concentration of ten (out of 18) carcinogenic PAHs (i.e.,
ΣcarcPAHs) was approximately 120 % higher when influenced
by tobacco smoke; the carcinogenic PAHs were predominant-
ly associated with fine particles (93–96 % ofΣcarcPAHs). Thus,
in order to protect public health, it is necessary to develop
strategies to reduce exposure to PM2.5, mainly related to
carcinogenic PAHs.
When the health risks associated with inhalation exposure
are evaluated by the TEF method, typically TEF values esti-
mated by Nisbet and LaGoy (1992) are used (Bari et al. 2010;
Halek et al. 2008; Mugica et al. 2010; Ohura et al. 2004).
However, Nisbet and LaGoy did not refer to the TEF value for
dibenzo[a ,l ]pyrene. As this PAH is considered relevant for
the respective evaluation, in this work, TEFs reported by
Muller (1997) (that included TEF for dibenzo[a ,l ]pyrene;
Boström et al. 2002) were used to calculate the TEF-
adjusted concentrations. Dibenzo[a ,l ]pyrene was previously
the least abundant PAH in both PM at both homes. Due to its
TEF of 100, dibenzo[a ,l ]pyrene became the largest contribu-
tor to ΣTEF-PAHs (80 and 70 % of ΣTEF-PAHs at smoking and
non-smoking home, respectively) and its TEF-adjusted con-
centration was 240 % higher when influenced by tobacco
smoke. This PAH is not commonly assessed when evaluating
particulate-bound PAHs, although its relative contribution to
carcinogenic potential is very strong, even at very low con-
centrat ions as demonstrated within this study.
Dibenz[a ,h ]anthracene (the most abundant PAH in both PM
at both homes) was the second largest contributor to ΣTEF-
PAHs with 14 and 21 % of ΣTEF-PAHs at smoking and non-
smoking home, respectively. In general, these results confirm
and emphasize the importance of the analysis and evaluation
of these two potent carcinogens that are being currently
discussed as possible surrogate compounds for PAH mixtures
from various environments (Okona-Mensah et al. 2005).
Finally, benzo[a ]pyrene was the third most abundant PAH
(5 and 6 % of ΣTEF-PAHs at smoking and non-smoking home,
respectively) with levels 130 % higher when influenced by
smoking. Overall, the obtained results allow concluding that
analysis of all three PAHs is relevant in relation to tobacco
smoke; the common approach of using benzo[a ]pyrene as an
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Fig. 2 Carcinogenic risks of PAHs in PM10 and PM2.5 at two homes. The
values represent sum of target carcinogenic risks of eight individual PAHs
(naphthalene, chrysene, benz[a ]anthracene, benzo[b ]fluoranthene,
benzo[k ]fluoranthene, indeno[1,2,3-cd]pyrene, benzo[a ]pyrene, and
dibenz[a ,h]anthracene); the horizontal black line represents USEPA
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Fig. 3 Compositional profiles of 18 PAH in PM10 and PM2.5 obtained at
indoor non-smoking home and in ambient air. The abundances of PAHs
in ambient air were retrieved from Slezakova et al. (2011)
indicator might lead to underestimating the potential carcino-
genic potency of PAHs in air.
Regarding the lung cancer risk via the inhalation route, the
World Health Organization suggested the unit risk of 8.7×
10−5 (ng m−3)−1 for lifetime (70 years) PAH exposure (Ohura
et al. 2004). Taking into the consideration that people spend
approximately 80 % of their time indoors, the estimated
lifetime lung cancer risks at the smoking home were 2.0×
10−3 for PAHs in PM2.5, being about 18 times lower for coarse
fraction (i.e., 1.1×10−4). At the non-smoking home, the cor-
responding values of lifetime lung cancer risks were lower,
with figures of 6.8×10−4 for PAHs in PM2.5 and 6.2×10
−5 for
PM2.5–10; PAHs in fine fraction exhibited risks about 11 times
higher than in PM2.5–10. It is important to point out that at both
homes risks estimated for both fine and coarse fractions
exceeded the health-based guideline level of 10−5 (Boström
et al. 2002). The exceedances were especially considerable for
PM2.5 with values 200 and 68 times higher than health-based
guideline at smoking home and non-smoking home, respec-
tively. These results thus demonstrate that particulate-bound
PAHs, and especially those from tobacco smoke represent a
serious health risk.
When evaluating carcinogenic risks associated with inha-
lation exposure to PAHs by USEPA methodology,
dibenzo[a ,l ]pyrene was not considered as its chronic inhala-
tion unit risk value is not available; therefore settling IUR
value for dibenzo[a ,l ]pyrene is important for the respective
risk analysis once this compound is a potent carcinogen
(Okona-Mensah et al. 2005). For carcinogens, USEPA set a
risk level of 10−6 for individual compounds and pathways
with the understanding that it will generally cause negligible
cancer risks. However, caution is recommended to ensure that
cumulative cancer risks of all potential carcinogenic compo-
nents do not have residual cancer risk exceeding 10−4. At
smoking home (Fig. 2), target carcinogenic risks exceeded
in both PM the USEPA health-based guideline level for 2
different age categories: adults with 25–54 years and seniors
(>65 years). These results confirm that tobacco smoke con-
siderably increases the carcinogenic risks. Furthermore, the
exposure to tobacco smoke combined with certain life style
(such as diet or regimen) may result in even increased cancer
risks related to these pollutants (Slezakova et al. 2011). At
non-smoking home, target carcinogenic risks were approxi-
mately twice lower than at smoking home. USEPA health-
based guideline was exceeded for one age category, namely
seniors, which suggest that long-term exposure to PAHs at
levels found at non-smoking home can eventually cause risks
for developing cancer. The high values of cancer risks in the
absence of smoking indicate a significant contribution of
PAHs from another source. The values of PM indoor/
outdoor ratios (lower than 1), indicate that outdoor emissions
can be a significant contributor to indoor levels (Castro et al.
2010). Therefore, Fig. 3 shows comparison between
compositional profiles of particulate-bound PAHs collected
indoors at non-smoking home and in ambient (outdoor) air.
The abundances of PAHs in ambient air were retrieved from
Slezakova et al. (2011) and corresponded to sampling period
of 40 days during November–December 2008 (i.e., previous
months to the indoor measurements). Despite the existing
limitations between both studies (different sampling period,
outdoor data collected at ground level, distance between both
sampling sites) composition profiles of PAHs at non-smoking
home were rather similar to those of ambient air. In addition,
Slezakova et al. (2013) has shown that vehicular road emis-
sions are the major source of ambient PAHs in the respective
area of Oporto. In a view of these findings, traffic emissions
thus can be a significant source of indoor PAHs. This is
especially relevant for homes in close vicinity to major roads
where vehicular emissions can be the major contributor of
indoor health-relevant pollutants; the risks associated with the
elevated concentrations in those indoor environments could
be significantly higher than those calculated in this work.
Conclusions
At the smoking home, the mean total concentrations of 18
PAHs was 17.1 and 16.6 ng m−3 in PM10 and PM2.5, respec-
tively. The corresponding concentrations were 2.3 times lower
at non-smoking home, with means of 7.60 ng m−3 in PM10
and 7.16 ng m−3 in PM2.5. PAHs with five and six rings
composed the majority of the particulate PAH content (i.e.,
73 and 78% ofΣPAHs at the smoking and non-smoking home,
respectively). Target carcinogenic risks exceeded USEPA
health-based guideline at smoking home for two different
age categories demonstrating that tobacco smoke consider-
ably increases the carcinogenic risks. The estimated values of
lifetime lung cancer risks largely exceeded (68–200 times) the
health-based guideline levels at both homes thus demonstrat-
ing that long-term exposure to PAHs at the respective levels
would eventually cause risk of developing cancer. In the
absence of smoking, the high achieved values of cancer risks
suggest a significant contribution of PAHs from outdoors.
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